Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002

Annals of Clinical Microbiology and Antimicrobials

Volumn 2, Issue , 2003, Pages

  Jenwitheesuk, Ekachai ^a,b   Watitpun, Chotip ^c   Vibhagool, Asda ^b   Chantratita, Wasun ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CODON; CONTROLLED STUDY; DNA SEQUENCE; GENE ISOLATION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; POPULATION RESEARCH; PREVALENCE; RNA ISOLATION; SEQUENCE ANALYSIS; STRUCTURAL GENE; THAILAND; VIRUS LOAD;

EID: 2542475871     PISSN: 14760711     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-0711-2-4     Document Type: Article

References (18)

1. Dietrich U, Ruppach H, Gehring S, Knechten H, Knickmann M, Jager H, Wolf E, Husak R, Orfanos CE, Brede HD, Rubsamen-Waigmann H and von Briesen H Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. AIDS 1997, 11:1532-1533
2. Yerly S, Kaiser L, Race E, Bru JP, Clavel F and Perrin L Transmission of antiretroviral-resistant HIV-1 variants. Lancet 1999, 354:729-733
3. Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, Tsay J, Ip J, Farthing C, Limoli K, Parkin N and Markowitz M HIV-1 drug resistance in newly infected individuals. JAMA 1999, 282:1135-1141
4. Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, Hellmann NS, Petropoulos CJ, Sutton L, Pitt JA, Rosenberg ES, Koup RA, Walker BD and Richman DD Reduced antiretroviral drug susceptibility among patients with primary HIV infection. JAMA 1999, 282:1142-1149
5. Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK, Barile A, VanCott TC, Vahey MT, McCutchan FE, Birx DL, Richman DD and Mascola JR Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 1999, 131:502-506
6. Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Cote P, LeBlanc R, Lefebvre E, Spira B, Tsoukas C, Sekaly RP, Conway B, Mayers D and Routy JP Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. AIDS 2000, 14:F17-F23
7. Wegner SA, Brodine SK, Mascola JR, Tasker SA, Shaffer RA, Starkey MJ, Barile A, Martin GJ, Aronson N, Emmons WW, Stephan K, Bloor S, Vingerhoets J, Hertogs K and Larder B Prevalence of genotypic and phenotypic resistance to antiretroviral drugs in a cohort of therapy-naive HIV-1 infected US military personnel. AIDS 2000, 14:1009-1015
8. Little S Transmission and prevalence of HIV resistance among treatment-naive subjects. Antiviral Ther 2000, 5:33-40.
9. Perez-Olmeda M, Del Romero J, Rubio A, Ruiz L, Rodriguez C, Leal M, Clotet B and Soriano V Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors. J Med Virol 2001, 63:85-87
10. Sirivichayakul S, Ruxrungtham K, Sa-nguansilp C and Phanuphak P High prevalence of multi-drug resistance mutations in Thai patients treated for prolonged period with double nucleosides [abstract TuPeB4605]. In Proceeding of XIV International AIDS conference: 2002 July 7-12; Barcelona, Spain
11. Cho YK, Sung H, Ahn SH, Bae IG, Woo JH, Won YH, Kim DG and Kang MW Frequency of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type-1 infected patients in Korea. J Clin Microbiol 2002, 40:1319-1325
12. UNAIDS/WHO epidemiological fact sheet on HIV/AIDS and sexually transmitted infections in Thailand, update
13. Kraisintu K Generic production of HIV/AIDS-related drugs in Thailand. In: Improving Access to Care in developing countries: lessons from practice, research, resources and partnerships. UNAIDS November - December 2001
14. Chantratita W, Jenwitheesuk E, Watitpun C, Pongthanapisith V, Vibhagool A, Leechawengwong M, Sookpranee M and Apairatana A Prevalence of HIV-1 polymerase gene mutations in pretreated patients in Thailand. Southeast Asian J Trop Med Public Health 2002, 33:80-84
15. Devereux H, Youle M, Johnson M and Loveday C Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy. AIDS 1999, 13:F123-F127
16. Verhofstede C, Wanzeele FV, Van der Gucht B, De Cabooter N and Plum J Interpretation of RTI or a switch from RTI to PI resulted in a fast reapperance of virus strains with a RT-sensitive genotype. AIDS 1999, 13:2541-2546
17. Shafer RW, Jung DR, Betts BJ, Xi Y and Gonzales MJ Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Research 2000, 28:346-348
18. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Rapp BA and Wheeler DL GenBank. Nucleic Acids Res 2002, 30:17-20